Showing results (1091-1100 of 1,110) with videos related to
Sort By:
Pageof 111
Trials|May 5, 2021
Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trialDeonna M Ackermann, Amelia K Smit, Monika Janda, et al.JAMA Dermatology|November 24, 2021
Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF): A Pilot Randomized Clinical TrialDeonna M Ackermann, Mbathio Dieng, Ellie Medcalf, et al.ACS Medicinal Chemistry Letters|April 21, 2015
Novel benzamide-based histamine h3 receptor antagonists: the identification of two candidates for clinical developmentMichael A Letavic, Leah Aluisio, Richard Apodaca, et al.The New England Journal of Medicine|June 11, 2025
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia BUlrike M Reiss, Andrew M Davidoff, Edward G D Tuddenham, et al.Kidney International Supplements|March 10, 2020
Considerations on equity in management of end-stage kidney disease in low- and middle-income countriesWim Van Biesen, Vivekanand Jha, Ali K Abu-Alfa, et al.Journal of Clinical Epidemiology|April 9, 2017
GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidenceVivian A Welch, Elie A Akl, Kevin Pottie, et al.JAMA Dermatology|March 11, 2026
Characteristics of Participants Screened and Randomized to the Melanoma Self Surveillance TrialEllie Medcalf, Deonna M Ackermann, Jake T W Williams, et al.Kidney International Supplements|March 10, 2020
Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the worldBarnaby Hole, Brenda Hemmelgarn, Edwina Brown, et al.The New England Journal of Medicine|November 20, 2014
Long-term safety and efficacy of factor IX gene therapy in hemophilia BAmit C Nathwani, Ulreke M Reiss, Edward G D Tuddenham, et al.The New England Journal of Medicine|December 14, 2011
Adenovirus-associated virus vector-mediated gene transfer in hemophilia BAmit C Nathwani, Edward G D Tuddenham, Savita Rangarajan, et al.Pageof 111